CDT Equity Sets 1-for-20 Reverse Stock Split, Effective Nov. 5
Split-adjusted shares are expected to begin trading on Nasdaq on Nov. 6, under the existing ticker CDT.
CDT Equity CDT
CDT Equity Inc. · Nasdaq · Pharmaceutical Preparations · also CDTTW
$0.07-4.29%close on Nov. 3, 2026 · volume 3.7M · Yahoo Finance
Price, last 51 sessions
Our coverage
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 28, 2026 | Andrew Regan with Corvus Capital Ltd. Chief Executive Officer, director, 10% owner · indirect | Sold amended | 29 | n/a | n/a |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 30 →Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
AI summary, unreviewedCDT Equity Inc. announces 1-for-20 reverse stock split effective November 5, 2026, cutting outstanding shares from 20,357,283 to about 1,017,864
Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCDT Equity Inc. Issues About 2.7 Million Shares in Manoira Evaluation Deal, Consulting, Financing and Former CEO Severance Settlement
Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits
AI summary, unreviewedCDT Equity Inc. Issues $6.75 Million Senior Secured Convertible Note to J.J. Astor & Co. With Floor-Price Reset and Dilution Risk